Examination of thromboxane synthase as a prognostic factor and therapeutic target in non-small cell lung cancer.
about
Simultaneous structure-activity studies and arming of natural products by C-H amination reveal cellular targets of eupalmerin acetate.Cyclooxygenases and lipoxygenases in cancer.The thromboxane synthase and receptor signaling pathway in cancer: an emerging paradigm in cancer progression and metastasis.18β-Glycyrrhetinic acid suppresses cell proliferation through inhibiting thromboxane synthase in non-small cell lung cancer.Novel hematopoietic target genes in the NRF2-mediated transcriptional pathway.Prostanoids receptors signaling in different diseases/cancers progression.Clinical models and biochemical predictors of VTE in lung cancer.Tobacco carcinogen NNK-induced lung cancer animal models and associated carcinogenic mechanisms.Protein kinase C-related kinase 1 and 2 play an essential role in thromboxane-mediated neoplastic responses in prostate cancer.Downregulation of TBXAS1 in an iron-induced malignant mesothelioma model.Thromboxane A2 exerts promoting effects on cell proliferation through mediating cyclooxygenase-2 signal in lung adenocarcinoma cells.Functional analysis of human thromboxane synthase polymorphic variants.Expression of the TPα and TPβ isoforms of the thromboxane prostanoid receptor (TP) in prostate cancer: clinical significance and diagnostic potential.Thromboxane A₂ receptor signaling facilitates tumor colonization through P-selectin-mediated interaction of tumor cells with platelets and endothelial cells.
P2860
Q30579599-A105F4DC-42CA-4073-89CF-EEEF09DB9C54Q34224752-1D078C50-D8F5-4D57-B809-047DBD5EFB52Q34228685-F7B93A87-F71F-4034-B9FC-621D0D5C8838Q35138733-EB97E27F-0AC2-4526-B6B6-0AE9EE99A571Q36916087-67B3D2EC-DA61-4E19-AC2C-FE65D1776371Q38074716-D2774552-C45B-4D41-A4DF-D9CE82640D87Q38205701-F3E04342-F1FD-4152-BB25-F5135D77D51AQ38514782-E059E257-709F-47EB-B578-DAA2752C92C3Q38841874-332E16EB-B2FB-494F-9E71-2BB0058EA102Q38849249-FAA45900-2975-432D-9BC2-C52A7E0B6F74Q39037809-BB5521AF-BBE8-47AF-8C4F-012A5E74CEDEQ40757621-DE7D7AF8-D699-42E0-AA82-9318599300A2Q42317551-A0EC1BC6-BA86-4242-B7F4-44317B3CD098Q53963727-568515B1-B146-4A99-BF49-DD7C00445D4E
P2860
Examination of thromboxane synthase as a prognostic factor and therapeutic target in non-small cell lung cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Examination of thromboxane syn ...... in non-small cell lung cancer.
@ast
Examination of thromboxane syn ...... in non-small cell lung cancer.
@en
Examination of thromboxane syn ...... in non-small cell lung cancer.
@nl
type
label
Examination of thromboxane syn ...... in non-small cell lung cancer.
@ast
Examination of thromboxane syn ...... in non-small cell lung cancer.
@en
Examination of thromboxane syn ...... in non-small cell lung cancer.
@nl
prefLabel
Examination of thromboxane syn ...... in non-small cell lung cancer.
@ast
Examination of thromboxane syn ...... in non-small cell lung cancer.
@en
Examination of thromboxane syn ...... in non-small cell lung cancer.
@nl
P2093
P2860
P356
P1433
P1476
Examination of thromboxane syn ...... in non-small cell lung cancer
@en
P2093
Elaine Kay
Graham P Pidgeon
Kenneth J O'Byrne
Mary-Clare Cathcart
Robert Cummins
P2860
P2888
P356
10.1186/1476-4598-10-25
P50
P577
2011-03-09T00:00:00Z
P5875
P6179
1044797897